Retour aux projets

18838.1 PFLS-LS

Development of early lead-like small molecules targeting a bacterial transcriptional regulator to treat infections caused by the Gram-negative pathogen Acinetobacter baumannii.

Résumé

Development of early lead-like small molecules targeting a bacterial transcriptional regulator to treat infections caused by the Gram-negative pathogen Acinetobacter baumannii.

Textes supplémentaires

Abstract

Acinetobacter baumannii is a Gram-negative bacterium of the ESKAPE-pathogen group and listed as one of the top priority dangerous organisms. The majority of clinical A. baumannii isolates (63%) are multidrug resistant. This project aims at developing an early lead-like small molecule against a transcriptional regulator of Acinetobacter ssp. These molecules will represent a new class of antibiotics active against a novel target family in Gram-negative antibacterial research.

Participants

Marc Gitzinger

Wirtschaftspartner

BioVersys AG Marc Gitzinger Hochbergerstrasse 60c 4057 Basel BS CH

Richard Kammerer

Kontaktperson

richard.kammerer@psi.ch

PSI, Paul Scherrer Institut Richard Kammerer OFLC/ 106 5232 Villigen PSI AG CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-02-28
Date de fin
2019-12-31
Coûts totaux approuvés
CHF 361238.00
Section
60 Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%